News & Press

Categories Everything • Press Releases • Media Coverage • Patents • Scientific Publications • Events

SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients

Christian Mygind 9/17/26 Christian Mygind 9/17/26

SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients

It all begins with an idea.

Read More

Christian Mygind 8/12/26 Christian Mygind 8/12/26

Expanded Access Case Report of SNIPR001, an Engineered CRISPR Medicine, in Rare Intracellular E. coli Disease Published in Clinical Infectious Diseases

It all begins with an idea.

Read More

Christian Mygind 3/3/26 Christian Mygind 3/3/26

SNIPR announces Publication of Final Positive Phase 1 Results for SNIPR001 in The Lancet Microbe

It all begins with an idea.

Read More

SNIPR Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance

Christian Mygind 8/7/25 Christian Mygind 8/7/25

SNIPR Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance

It all begins with an idea.

Read More

SNIPR Announces First Patient Dosed in its Phase 1b Clinical Trial of SNIPR001 in Patients with Hematological Cancer

Christian Mygind 7/7/25 Christian Mygind 7/7/25

SNIPR Announces First Patient Dosed in its Phase 1b Clinical Trial of SNIPR001 in Patients with Hematological Cancer

It all begins with an idea.

Read More

Christian Mygind 12/9/24 Christian Mygind 12/9/24

SNIPR receives up to EUR 20 million from European Investment Bank (EIB) to advance therapies against microbial resistance

It all begins with an idea.

Read More

SNIPR receives funding for the development of CRISPR-medicines to improve Environmental Enteric Dysfunction (EED) in pregnant women

Christian Mygind 6/28/24 Christian Mygind 6/28/24

SNIPR receives funding for the development of CRISPR-medicines to improve Environmental Enteric Dysfunction (EED) in pregnant women

It all begins with an idea.

Read More

Christian Mygind 4/22/24 Christian Mygind 4/22/24

SNIPR receives USD 5.48 million funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials

It all begins with an idea.

Read More

SNIPR has research findings published in Nature Biotechnology

Christian Mygind 5/4/23 Christian Mygind 5/4/23

SNIPR has research findings published in Nature Biotechnology

It all begins with an idea.

Read More

SNIPR Launches A Non-Profit Patent Licensing Program To Enable The Field of CRISPR Editing in Prokaryotes

Christian Mygind 10/3/22 Christian Mygind 10/3/22

SNIPR Launches A Non-Profit Patent Licensing Program To Enable The Field of CRISPR Editing in Prokaryotes

It all begins with an idea.

Read More